In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for applications including regulatory decisions, health technology assessment (HTA), pharmacovigilance and more. However, Asia currently lacks a framework to effectively collect and utilize a broad range of RWD/RWE.
Here John Pracyk, MD, PhD, MBA, MAPS President of the Americas Region speaks with some of the top Medical Affairs leaders from Johnson & Johnson as they share their perspective on the impact of Digital on Healthcare.
In this webinar, three panelists explain how medical information teams are transforming customer experience through digital technology.
This podcast focuses on the journal publishing industry, discussing how medical journal publishing is changing and what changes we might see in the future.
Survey benchmarks External Education trends and needs to inform structure, capabilities, strengths and gaps that can be leveraged for planning in your organization.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
This MAPS podcast details potential areas for compliant collaboration by MSLs with Academic Drug Developers.
This MAPS podcast details potential areas for compliant collaboration by MSLs with Patient Advocacy Groups.
This 2021 Benchmark Report is based on findings from 21 leading industry organizations regarding their organizational structure, budget, and operations.